Correlation Between Cue Biopharma and Ardelyx
Can any of the company-specific risk be diversified away by investing in both Cue Biopharma and Ardelyx at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cue Biopharma and Ardelyx into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cue Biopharma and Ardelyx, you can compare the effects of market volatilities on Cue Biopharma and Ardelyx and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cue Biopharma with a short position of Ardelyx. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cue Biopharma and Ardelyx.
Diversification Opportunities for Cue Biopharma and Ardelyx
0.22 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Cue and Ardelyx is 0.22. Overlapping area represents the amount of risk that can be diversified away by holding Cue Biopharma and Ardelyx in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ardelyx and Cue Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cue Biopharma are associated (or correlated) with Ardelyx. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ardelyx has no effect on the direction of Cue Biopharma i.e., Cue Biopharma and Ardelyx go up and down completely randomly.
Pair Corralation between Cue Biopharma and Ardelyx
Considering the 90-day investment horizon Cue Biopharma is expected to generate 1.57 times more return on investment than Ardelyx. However, Cue Biopharma is 1.57 times more volatile than Ardelyx. It trades about 0.02 of its potential returns per unit of risk. Ardelyx is currently generating about 0.02 per unit of risk. If you would invest 104.00 in Cue Biopharma on December 27, 2024 and sell it today you would lose (3.50) from holding Cue Biopharma or give up 3.37% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Cue Biopharma vs. Ardelyx
Performance |
Timeline |
Cue Biopharma |
Ardelyx |
Cue Biopharma and Ardelyx Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Cue Biopharma and Ardelyx
The main advantage of trading using opposite Cue Biopharma and Ardelyx positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cue Biopharma position performs unexpectedly, Ardelyx can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ardelyx will offset losses from the drop in Ardelyx's long position.Cue Biopharma vs. Coya Therapeutics, Common | Cue Biopharma vs. Lantern Pharma | Cue Biopharma vs. Fennec Pharmaceuticals | Cue Biopharma vs. Anixa Biosciences |
Ardelyx vs. BioLineRx | Ardelyx vs. Lexicon Pharmaceuticals | Ardelyx vs. Seres Therapeutics | Ardelyx vs. Immunitybio |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Other Complementary Tools
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |